Indications and uses
For temporary relief of mild symptoms of intermittent asthma: Wheezing Tightness of chest Shortness of breath
For temporary relief of mild symptoms of intermittent asthma: Wheezing Tightness of chest Shortness of breath
The ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine. Do not use more than directed For use with a Jet Nebulizer. Add 0.5 mL (contents of one vial) of solution to Nebulizer. Adults and children 4 years of age and over: 1 to 3 inhalations not more often than every 3 hours. Do not use more than 12 inhalations in 24 hours. The use of this product by children should be s...
Racepinephrine, USP 11.25 mg (as 13.5 mg of Racepinephrine HCl, USP).
Bronchodilator
For temporary relief of mild symptoms of intermittent asthma:
Wheezing
Tightness of chest
Shortness of breath
Asthma alert: Because asthma may be life threatening, see a doctor if you:
These may be signs that your asthma is getting worse.
Do not use:
Ask a doctor before use if you have:
Ask a doctor or pharmacist before use if you are:
Stop use and ask a doctor if:
When using this product:
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
1 to 3 inhalations not more often than every 3 hours.
Do not use more than 12 inhalations in 24 hours.
The use of this product by children should be supervised by an adult.
Storage and Handling
Protect from light. Avoid excessive heat. Protect from freezing.
Store between 2°C and 25°C (36°F and 77°F).
How Supplied: BeC ® Racepinephrine Inhalation Solution, USP 2.25% is supplied in 0.5 mL sterile vials.
30 vials, each vial in an individual pouch.
Ascorbic acid, citric acid, edetate disodium, water.
1 (855) 860-3404
support@blueechocare.com
Monday through Friday, 8:00 a.m. to 5:00 p.m. (Pacific Standard Time).
Manufactured By:
Blue Echo Care LLC
3639 SE 21st Ave
Portland, OR 97202 USA
Contains 30 BeC® Racepinephine vials
Racepinephine
Racepinephrine Inhalation Solution Bronchodilator
FOR TEMPORARY RELIEF
OF MILD SYMPTOMS OF
INTERMITTENT ASTHMA
Important: Do not exceed recommended dose.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73117-518-17 | 2025-09-22 | C162847 | 48780-1 | 3b156c62-2b92-fb37-e063-e6dba90a4e07 | 30e35101-fa7b-536f-e063-6394a90a6e53 |
| 73117-518-17 | 2025-07-29 | C162847 | 48780-1 | 3b156c62-2b92-fb37-e063-e6dba90a4e07 | 30e35101-fa7b-536f-e063-6394a90a6e53 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73117-518 | 73117-518-17 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| RACEPINEPHRINE HYDROCHLORIDE | 336096P2WE | ACTIM |
| ASCORBIC ACID | PQ6CK8PD0R | IACT |
| WATER | 059QF0KO0R | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 34851181-c9ff-0e15-e063-6294a90a459d | 30e35101-fa7b-536f-e063-6394a90a6e53 | 2025-05-07 | Warnings | 34851181-c9ff-0e15-e063-6294a90a459d 30e35101-fa7b-536f-e063-6394a90a6e53 |
Adverse event summaries are temporarily unavailable. Other product information remains available.